Anteo Diagnostics Limited (Anteo) formerly known as BioLayer Corporation Limited has developed a platform for the rapid design of novel materials for the biotechnology, diagnostics and pharmaceutical industries. Its current focus is the clinical diagnostic industry, particularly, the in vitro diagnostics (IVD) markets (nano- and micron-sized bead manufacturers and IVD suppliers), Point of Care markets (membrane producers and PoC suppliers), and scientific and clinical research markets (bead, membrane and instrument producers). The company has developed a number of binding methods that reduce damage to biological molecules, such as antibodies when they are placed on artificial or synthetic surfaces. Its products are marketed and sold in domestic and international market through its own sales force. Anteo is headquartered in Queensland, Australia.